Publications
| Title | Publication Date | Price |
|---|---|---|
Bioinformatics Partnering Terms and Agreements3rd Edition Provides comprehensive insight into bioinformatics partnering deals and agreements entered into by leading healthcare companies. | March 2013 | £1,850 |
Partnering Deals and Alliances with Big Pharma6th Edition Provides comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies. | February 2013 | £1,980 |
Practical Guide to Finding PartnersProvides a comprehensive overview of the steps required to identify and secure potential partnering opportunities | January 2013 | £860 |
Vaccine Partnering Terms and Agreements4th Edition Provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. | January 2013 | £1,780 |
Monoclonal Antibody Partnering Terms and AgreementsMonoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the worlds leading healthcare companies. | December 2012 | £1,670 |
Partnering and M&A YearbookYearbook 2012 Provides comprehensive understanding and unprecedented access to the partnering and M&A deals and agreements entered into by the worlds leading healthcare companies during 2011. | January 2012 | £1,910 |
Orphan Drug Markets in EuropeKey developments and the strategies of major pharmaceutical companies A comprehensive overview of orphan drugs in Europe and future opportunities. | November 2011 | £1,495 |
Healthcare & Pharmaceuticals in Latin AmericaA guide to the markets and regulations A comprehensive overview of the healthcare market in Latin America including Argentina - Belize – Bolivia – Brazil – Chile – Colombia - Costa Rica - Costa Rica – Ecuador - El Salvador – Guatemala – Honduras - Mexico - Nicaragua – Panama – Paraguay – Peru – Uruguay – Venezuela | September 2011 | £995 |
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018Future Therapies for Birth Control and Reproductive Health Provides analysis of over ten key marketed products and indentifies over 40 R&D candidates in preclinical to clinical stages of development. | May 2011 | £1,795 |
The Global Cancer Vaccine MarketPipeline Analysis and Future Market Impact (2nd Ed) Covers key therapeutic cancer vaccine candidates in late-phase development based on sales forecasts to 2020 | January 2011 | £1,700 |